PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Terlipressin relieves intestinal and renal injuries induced by acute mesenteric ischemia via PI3K/Akt pathway.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33162803 ↗2020Reported benefit

Terlipressin relieves intestinal and renal injuries induced by acute mesenteric ischemia via PI3K/Akt pathway.

RatIschaemia-reperfusionIntestinal / mesentericSprague-Dawley (specific pathogen free)MaleIntravenous via femoral vein cannula0.5 mL of an 8 microgram/mL terlipressin solution as a bolu…Bolus given immediately after unclamping of the superior mesenteric artery, wit…

Model: Acute mesenteric ischaemia-reperfusion: superior mesenteric artery clamped with a microaneurysm clip for 1 h followed by reperfusion, under pentobarbital anaesthesia (30 mg/kg intraperitoneally) and mechanical ventilation, with midline laparotomy

Terlipressin and norepinephrine both restored mean arterial pressure, reduced intestinal and renal injury scores, lowered blood urea nitrogen and creatinine, and improved survival compared with untreated mesenteric ischaemia (mortality 85.7% with a median survival of 3 h). Only terlipressin reduced…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.